You cannot register for this webinar

Keiretsu SoCal Investor Forum --- 10:00 AM Discover innovative opportunities to invest in. Participating companies: Compact Medical Compact Medical received FDA clearance for their product, the ButterflyBVM™ in April 2025. They have secured pre-orders for over 2,300 units and are shipping the first orders to customers in July. They are looking for a partner to scale a nationwide launch of their lifesaving device. Eyetronic Eyetronic is a CE certified, non-invasive optic nerve stimulation therapy with more than 1,000 patients treated in 10,000 sessions. Treatment is outpatient and pain-free. Not one single SAE has been observed. Peer-reviewed published clinical results show improved vision in 59%-78% at one-year follow-up. Business model is SaaS. US clinical trials start in June 2025 for US launch in 2028. Updates: BleedIO Tech This week at the TechConnect Worldwide Summit, BleedIO Tech presented their technology three times, received two awards, and saw strong interest from major organizations like Chevron, DOD, and Tulane. In Austin, BleedIO completed their first U.S. installation in just 15 minutes. They also launched a smart city project with San Antonio and continue active work with UTSA. Paulex Bio Imagine a world without diabetes. Paulex Bio stands on the threshold of what could be a transformative breakthrough for Type 1 and Type 2 diabetes: an oral medicine designed to stimulate the regeneration of human beta cells to restore natural insulin production and potentially offer insulin independence to patients across the diabetes spectrum. Rising Wines Collective Rising Wines Collective is scaling small-production wine sales through a DTC marketplace, offering curated clubs and direct access to craft winemakers. We’re building a suite of data-driven engagement tools—including an AI Wine Stylist app and custom-fit club—reimagining wine discovery with unmatched personalization and a modern approach traditional retailers can’t replicate.